SlideShare a Scribd company logo
1 of 16
Download to read offline
Priority ssistive Products List
The Initiative
Improving access to assistive technology
for everyone, everywhere
EQUIPPING, ENABLINGAND EMPOWERING
Photo:CBM/FotoBackofenMhm
Improving access to
assistive technology
for everyone,
everywhere
Introduction
WHO estimates that over one billion people need
one or more assistive products. The majority of these
are older people and people with disabilities. As
people age, including those with disabilities, their
function declines in multiple areas and their need
for assistive products increases accordingly. As the
global population progressively ages and prevalence
of noncommunicable diseases rises, the number of
people needing assistive products is projected to
increase to beyond two billion by 2050.
Assistive products enable people to live healthy,
productive, independent and dignified lives; to
participate in education, the labour market and civic
life. Assistive products can also help to reduce the need
for formal health and support services, long-term care
and the work of caregivers. Without assistive products,
people may suffer exclusion, are at risk of isolation and
poverty, and may become a burden to their family and
on society.
The positive impact of assistive products goes far
beyond improving the health and well-being of
individual users and their families. There are also
socioeconomic benefits to be gained, by virtue of
reduced direct health and welfare costs (such as
recurrent hospital admissions or state benefits), and
by enabling a more productive labour force, indirectly
stimulating economic growth.
Today, even before the predicted steep increases
in need for assistive products are established, only
around 10% of those in need have access to them. This
is due to high costs, limited availability and inadequate
financing in many settings, as well as a widespread lack
of awareness and suitably trained personnel.
To improve access to high quality, affordable assistive
products in all countries, the World Health Organization
(WHO) is introducing the Priority Assistive Products
List (APL). The APL is the first stage of implementing
a global commitment to improve access to assistive
products – the Global Cooperation on Assistive
Technology (GATE).
The APL includes 50 priority assistive products,
selected on the basis of widespread need and impact
on a person’s life. The list will not be restrictive; the aim
is to provide Member States with a model from which
to develop a national priority assistive products list
according to national need and available resources.
Like the WHO Model List of Essential Medicines, the
APL can also be used to guide product development,
production, service delivery, market shaping,
procurement, and reimbursement policies (including
insurance coverage).
The APL will support Member States to fulfil their
commitment to improve access to assistive products
– as mandated by the United Nations Convention on
the Rights of Persons with Disabilities (CRPD). More
than 162 Member States have ratified the CRPD, thus
committing to ensure access to assistive technology
at an affordable cost, and to foster international
cooperation in order to achieve this goal (Articles 4, 20,
26 and 32).
Member States have also endorsed the Sustainable
Development Goals (SDGs). Universal health coverage
is central to SDG goal 3 (Ensure healthy lives and
promote well-being for all at all ages). Promoting access
to assistive products needs to be an integral part of
universal health coverage if the SDGs are to be attained.
The APL aspires to follow in the footsteps of the WHO
Model List of Essential Medicines, which creates
awareness among the public, mobilizes resources and
stimulates competition. It has also supported countries
to develop national lists to promote access in their
own contexts. The APL is similarly intended to be a
catalyst in promoting access to assistive technology –
everywhere and for everyone.
More broadly, the GATE Initiative will support the WHO
global strategy on people-centred, integrated health
services across the life span, as well as action plans
on noncommunicable diseases, ageing and health,
disability, and mental health.
Assistive technology is the application of organized
knowledge and skills related to assistive products,
including systems and services. Assistive technology
is a subset of health technology.
Assistive products: Any external product (including
devices, equipment, instruments or software),
especially produced or generally available, the
primary purpose of which is to maintain or improve
an individual’s functioning and independence, and
thereby promote their well-being. Assistive products
are also used to prevent impairments and secondary
health conditions.
Priority assistive products: Those products that are
highly needed, an absolute necessity to maintain or
improve an individual’s functioning and which need to
be available at a price the community/state can afford.
DEFINITIONS
1
ASSISTIVE
PRODUCTS
AREESSENTIAL
TOOLSTO:
getting out of bed
and out of one’s
house
compensate for
an impairment/
a loss of intrinsic
capacity
older
people
reduce the
consequences
of gradual
functional
decline
people with
disability
people with
noncommunicable
diseases
people with mental
health conditions
including dementia
and autism
people with
gradual
functional
decline
help minimize
the need for
caregivers
prevent primary
and secondary
health
conditions
lower health
and welfare
costs
accessing
education,
work and
employment
escaping from
poverty and
hunger
greater mobility,
freedom and
independence
inclusion and participation
leading
a dignified
life
Who needs
assistive technology?
2
THEPEOPLE
WHOMOST
NEEDASSISTIVE
TECHNOLOGY
INCLUDE:
ASSISTIVE
PRODUCTS ARE
OFTENTHEFIRST
STEPTOWARDS:
Challenges in access
In 2011, the WorldReportonDisability
collated evidence for the global
unmet need for assistive products
of all kinds. We now know that many
people have little or no access to
basic assistive products, even in
some high-income countries. Today,
few countries have national assistive
technology policies or programmes.
As a result, access to assistive
products is far from universal: the
majority are left behind.
In many countries, access to assistive
products in the public sector is
particularly poor or non-existent,
leading to high out-of-pocket
payments that are a burden for users
and their families. People from the
poorer sectors of society frequently
rely on donations or charitable
services, which often focus on
provision of large quantities of sub-
standard or used products. These
are often not appropriate for the user
or the context, and may even cause
secondary health complications or
premature death. Similar scenarios
are common in emergency response
programmes, where the need for
assistive products is high but often
neglected.
Affordable and appropriate access
requires government commitment to
adequate and sustained financing,
including efficient procurement of
appropriate assistive products and
delivery systems. In many high-
income countries, people are able to
access assistive products via health
or welfare systems. Where services
exist, they are often stand-alone
and fragmented. People must often
attend multiple appointments at
different locations, which are costly
and add to the burden on users and
caregivers, as well as on health and
welfare budgets.
The assistive products industry
is currently limited and extremely
specialized, primarily serving the
requirementsofhigh-incomesettings.
There is a general lack of state
funding, nationwide service delivery
systems, user-centred research and
development, procurement systems,
quality and safety standards, and
context-appropriate product design.
Trained personnel are essential for
the proper prescription, fitting, user
training, follow-up and maintenance
of assistive products. Without these
key steps, assistive products are often
abandoned, of little benefit or harmful,
all of which result in extra health care/
welfare costs.
By supporting coherent, prioritized
national assistive technology policies
and programmes, the APL is a
potential game-changer in improving
access to assistive products globally.
3
1 Alarm signallers with
light/sound/vibration
2 Audioplayers with
DAISY capability
3 Braille displays
(note takers)
4 Braille writing
equipment/braillers
5 Canes/sticks
6 Chairs for shower/
bath/toilet
7 Closed captioning
displays
8 Club foot braces
9 Communication
boards/books/cards
10 Communication
software
11 Crutches, axillary/
elbow
12 Deafblind
communicators
Priority ssistive Products List
4
13 Fall detectors
14 Gesture to voice
technology
15 Global positioning
system (GPS) locators
16 Hand rails/grab bars
17 Hearing aids (digital)
and batteries
18 Hearing loops/FM
systems
19 Incontinence
products, absorbent
20 Keyboard and mouse
emulation software
21 Magnifiers, digital
hand-held
22 Magnifiers, optical
23 Orthoses, lower limb
24 Orthoses, spinal
The Initiative
Equipping, enabling and empowering
5
25 Orthoses, upper limb
26 Personal digital
assistant (PDA)
27 Personal emergency
alarm systems
28 Pill organizers
29 Pressure relief
cushions
30 Pressure relief
mattresses
31 Prostheses, lower
limb
32 Ramps, portable
33 Recorders
34 Rollators
35 Screen readers
36 Simplified mobile
phones
Priority ssistive Products List
6
The Initiative
Improving access to assistive technology
for everyone, everywhere
37
Spectacles; low vision,
short distance, long
distance, filters
and protection
38 Standing frames,
adjustable
39
Therapeutic footwear;
diabetic,
neuropathic,
orthopaedic
40 Time management
products
41 Travel aids, portable
42 Tricycles
43 Video communication
devices
44 Walking frames/
walkers
45 Watches, talking/
touching
46 Wheelchairs, manual
for active use
47 Wheelchairs, manual
assistant-controlled
48 Wheelchairs, manual
with postural support
49 Wheelchairs,
electrically powered
50 White canes
7
8
Development of the APL
The APL has taken over a year to develop and has
involved extensive consultation with experts, including
users and their caregivers. The development of the APL
has involved four interlinked steps:
1. SCOPING REVIEW
A scoping review was carried out to gather evidence
from the literature on the efficacy of various assistive
products in maintaining or improving an individual’s
functioning, independence, quality of life or well-being.
Electronic searches in eight databases for articles
published between 2000 and 2014 generated 10,961
hits. Following multistage screening, 205 articles were
included for data extraction.
2. DELPHI EXERCISE
For the first round of a Delphi exercise, 150 assistive
products were identified from the reviewed articles
and included in a preliminary list. The products were
divided into six broad domains (mobility, vision,
hearing, communication, cognition and environment).
Disability and ageing data from 50 countries were
analysed to estimate the need within each domain,
and a fixed number of products was allocated to each
domain accordingly.
The preliminary list was piloted with 30 assistive
technology experts from 22 countries. The pilot
resulted in an expanded list of 155 products which was
used for the first round of the Delphi exercise.
A call to take part in the Delphi exercise was sent
to assistive technology stakeholders, including
professionals and users’ organizations. 200
stakeholders from 52 countries responded. The Delphi
exercise consisted of three rounds:
Round 1: Participants received a preliminary list of 155
assistive products. They were asked to review the list
and propose any additional products that should be
included. As a result, an additional 45 products were
added to the list.
Round 2: Participants received the extended list of 200
products and were asked to select up to 100 assistive
products that should be given priority.
Round 3: Participants received a list of the 100 highest
ranked products from Round 2. They were asked to
select up to 50 assistive products that should be given
priority.
3. GLOBAL SURVEY
To capture the opinions of a larger global population,
especially those of users and caregivers, a global
survey in 52 languages was launched and made
available online for three months. From the list of 100
products generated in Delphi Round 2, respondents
were asked to select up to 50 assistive products that
they thought should be given priority. The survey was
widely disseminated by Member States, UN agencies,
WHO offices, collaborating centres and partners, and
the International Disability Alliance. 10,208 people
from 161 countries took part in the survey, 44% of
whom were older people or people with disabilities.
The survey succeeded in reaching people with diverse
linguistic and socioeconomic backgrounds.
4. CONSENSUS MEETING
A two-day consensus meeting was held at WHO
headquarters in Geneva, on 21–22 March 2016 to
finalize the APL. Seventy participants attended the
meeting with representation from every WHO region.
The meeting included people working in service
provision and at a policy level, researchers and
representatives from organizations for people with
disabilities and older people, as well as individual users
of assistive products. Following extensive discussion
and deliberation, an overwhelming consensus was
reached on the final list of 50 priority assistive products.
9
In order to have maximum possible impact, the APL
needs to be supported with additional policy and
legislation, resources, and personnel working within
integrated health services. Hence, WHO is in the
process of developing three additional tools to assist
MemberStatestodevelopnationalassistivetechnology
policies and programmes, as an integral component of
universal health coverage. These tools include:
Policy: Assistive technology policy
framework
WHO will assist Member States to initiate national policy
dialogues to develop national assistive technology
programmes. A WHO Model assistive technology policy
framework will support this process, with best practice
examples. It will include financing mechanisms, such
as health and welfare insurance programmes, to help
ensure sustainability of service provision and universal
access. The policy framework will also include
guidance on implementation of the APL, standards,
training, and service delivery systems.
Personnel: Assistive products training
package
WHO will support Member States to develop the
capacity of their health workforce through an assistive
products training package. Existing health and
rehabilitation personnel will add to their skillset in order
to provide a range of basic assistive products at the
primary health care or community level, including the
training of formal and informal caregivers. For assistive
products that require specialist training (for example,
prostheses or spectacles for low vision), WHO will
work with Member States to explore possibilities for
increasing local or regional capacity for specialist
training. The assistive products training package
will include four essential steps of service provision:
assessment, fitting, training, and follow-up and repair.
Next steps
10
Provision: Assistive products service
delivery model
A network of specialist referral centres connected
to primary health care infrastructure is needed for
universal access to assistive products, and to ensure
early intervention. WHO will support Member States
to develop a model service delivery system that is best
suited for their specific needs. This will enable people to
access assistive products for all their functional needs
from a single point. WHO will work with Member States
to ensure that the service delivery of assistive products
becomes an integral part of the health/social welfare
system.
For further details:
The GATE initiative is hosted by the department of
essential medicines and products and works across
other departments within WHO. For more information:
http://www.who.int/phi/implementation/
assistive_technology/en/
11
Acknowledgements
Thank you to the following organizations, which have
contributed to the development of the APL: Abilia,
African Federation of Orthopaedic Technicians,
Alzheimer’s Disease International, Association for the
Advancement of Assistive Technology in Europe,
Canadian Continence Foundation, CBM, CBR Global
Network, CBR India Network, CBR Malaysia Network,
China Assistive Devices and Technology Centre for
Persons with Disabilities, China Disabled Persons’
Federation, Doro, European Assistive Technology
Information Network, Fondazione Don Carlo
Gnocchi, Foreningen Norges døvblinde, Handicap
International, HelpAge International, Hong Kong
Society for Rehabilitation, Instituto de Medicina Física e
Reabilitação do Hospital das Clínicas da Faculdade de
Medicina da Universidade de São Paulo, International
Committee of the Red Cross, International Disability
Alliance, International Society of Prosthetics and
Orthotics, International Working Group on the Diabetic
Foot, Motivation Australia, Mobility India, Motivation
UK, National Rehabilitation Centre for Persons with
Disabilities Japan, Office of UN Special Envoy,
Perkins School for the Blind, Perspektiva, Ottobock,
Rehabilitation Engineering and Assistive Technology
Society of Korea, Rehabilitation Engineering and
Assistive Technology Society of North America,
Rehabilitation Engineering Society of Japan, Sanchar,
SINTEF, Stellenbosch University, Trinity College Dublin
Centre for Global Health, United States Agency for
International Development, UCP Wheels for humanity,
Uhambo Foundation, University of Colombo, University
of Pittsburgh, World Blind Union, World Confederation
of Physical Therapy, World Federation of Occupational
Therapists, Zuyd University of Applied Sciences.
We also thank the following individuals, who have
also contributed to the development of the APL:
Martin Aker, Michael Allen, Serap Alsancak, Natasha
Altin, Renzo Andrich, Ismet Bajrami, Arjen Bergsma,
Girma Bireda Assena, Johan Borg, Penny Bundoc,
Tomas Čereška, Gautam Chowdhury, Cristina Maria
Correia Cardoso, Jie Dai, Alireza Darvishy, Tulika Das,
Luc De Witte, Mareike Decker, Sunil Deepak, Vinicius
Delgado Ramos, Biushnu Dhungana, Mukesh Doshi,
Pham Dung, Robi Kishore Dutta, Valerio Gower, Edith
Hagedoren, Zee-A Han, Kristin Horn, Yunyi Hu, Eldar
Husanovic, Erlisi Iljazi, Eduardo Inglez Yamanaka,
Cristian Ispas, Vilija Juškienė, Norah Keitany, Nejla
Khadri, Mohammed Khadri, Razi Khan, Zia Khan,
Phatcharaporn Kongkerd, Anarème Kpandressi, Hung
Hei Kwan, Anna Lapinska, Frank Lunde, Maryam
Mallick, Katerina Mavrou, Padmani Mendis, Satish
Mishra, Inchyuk Moon, Nela Mujacic, Farzaneh
Naghshineh, Kozo Nakamura, Yoko Nishimura, Achille
Otou-Essono, Timothee Pakouyowou, Jingwen Peng,
Tanya Prasolava, Sheila Purves, Malek Qutteina,
Ganna Radysh, Uta Roentgen, Joan Ruto, Dovilė
Sabaliauskaitė, Kjersti Sagstad, Daniel Scheidegger,
Christian Schlierf, Albina Shankar, Dusan Simsik, Anna
Söderberg, Terje Sund, Inoue Takenobu, Claude Tardif,
Ephrem Taye, Damaijanti Teguh, Outi Töytäri, Patricia
Traub, Kai Ming Tsui, Batdulam Tumenbayar, Isabelle
Urseau, Miguel Ángel Valero Duboy, Isabel Valle
Gallego, Armando Jose Vasquez, Prashannata Wasti,
Wang Wei, Petra Winkelmann, Cheryl Ann Xavier, Nan
Xia, Noor Yasmin, Diana Zandi, Yan Zhang.
12
WHO/EMP/PHI/2016.01
© World Health Organization 2016
All rights reserved. Publications of the World Health Organization are available on the WHO website (http://www.
who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27,
Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; email: bookorders@who.int).
Requests for permission to reproduce or translate WHO publications – whether for sale or for non-commercial
distribution – should be addressed to WHO Press through the WHO website (http://www.who.int/about/licensing/
copyright_form/en/index.html).
The designations employed and the presentation of the material in this publication do not imply the expression of
any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country,
territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and
dashed lines on maps represent approximate border lines for which there may not yet be full agreement.
The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed
or recommended by the World Health Organization in preference to others of a similar nature that are not
mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital
letters.
All reasonable precautions have been taken by the World Health Organization to verify the information contained
in this publication. However, the published material is being distributed without warranty of any kind, either
expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no
event shall the World Health Organization be liable for damages arising from its use.
Financial support: US Agency for International Development
Printed in France
Designed by Inís Communication – www.iniscommuniation.com
Photo credits: Abilia, Cedaf/Guatemala/Patricia Catellanos de Muñoz, WHO/Eduardo Martino, WHO/Pakistan,
WHO/Pierre Virot, WHO/SEARO/Vismita Gupta-Smith
The Initiative
Photo:KAPADKROPP(E.OhlsonWallinandL.Axelsson)©ScandinavianOrthopaedicLab.

More Related Content

Viewers also liked

A Gremlin ate my graph
A Gremlin ate my graphA Gremlin ate my graph
A Gremlin ate my graphDamien Seguy
 
CLASE 5 Gruposde google
CLASE 5 Gruposde googleCLASE 5 Gruposde google
CLASE 5 Gruposde googlejemalaga
 
50 Highlights der 37. Auktion am 18. April 2015 - 50 Highlights of Scripophil...
50 Highlights der 37. Auktion am 18. April 2015 - 50 Highlights of Scripophil...50 Highlights der 37. Auktion am 18. April 2015 - 50 Highlights of Scripophil...
50 Highlights der 37. Auktion am 18. April 2015 - 50 Highlights of Scripophil...Matthias Schmitt
 
Ort business breakfast mailer deloitte final
Ort business breakfast mailer deloitte finalOrt business breakfast mailer deloitte final
Ort business breakfast mailer deloitte finalekagan
 
InstantFiler oct 2010
InstantFiler oct 2010InstantFiler oct 2010
InstantFiler oct 2010Uniport Ltd.
 
REGIONE VENETO - Turismo flash - Febbraio 2011
REGIONE VENETO - Turismo flash - Febbraio 2011REGIONE VENETO - Turismo flash - Febbraio 2011
REGIONE VENETO - Turismo flash - Febbraio 2011BTO Educational
 
Curriculum Vitae Gianluca Dusio
Curriculum Vitae Gianluca DusioCurriculum Vitae Gianluca Dusio
Curriculum Vitae Gianluca DusioGianluca Dusio
 
E2M - Full 3D Black Box Navigation Application for Android
E2M - Full 3D Black Box Navigation Application for AndroidE2M - Full 3D Black Box Navigation Application for Android
E2M - Full 3D Black Box Navigation Application for AndroidTerry Kim
 
1 han va cat_trong_dong_tau
1 han va cat_trong_dong_tau1 han va cat_trong_dong_tau
1 han va cat_trong_dong_tauHien Dinh
 
Institucional Agroads.com 2013
Institucional Agroads.com 2013Institucional Agroads.com 2013
Institucional Agroads.com 2013Daniel Rodríguez
 
Formato hv foto sena copia2 sammymar
Formato hv foto sena   copia2 sammymarFormato hv foto sena   copia2 sammymar
Formato hv foto sena copia2 sammymarAndreita Gomez
 
Haris Hamza- Resume
Haris Hamza- ResumeHaris Hamza- Resume
Haris Hamza- ResumeHaris Hamza
 
La imagen educativa - Cómo se escribe
La imagen educativa - Cómo se escribeLa imagen educativa - Cómo se escribe
La imagen educativa - Cómo se escribeCastilloPalma
 
gestion infraestructura vial
gestion infraestructura vialgestion infraestructura vial
gestion infraestructura vialMiller2013
 

Viewers also liked (20)

Mercado de valores
Mercado de valores Mercado de valores
Mercado de valores
 
A Gremlin ate my graph
A Gremlin ate my graphA Gremlin ate my graph
A Gremlin ate my graph
 
Cumple de luis
Cumple de luisCumple de luis
Cumple de luis
 
CLASE 5 Gruposde google
CLASE 5 Gruposde googleCLASE 5 Gruposde google
CLASE 5 Gruposde google
 
50 Highlights der 37. Auktion am 18. April 2015 - 50 Highlights of Scripophil...
50 Highlights der 37. Auktion am 18. April 2015 - 50 Highlights of Scripophil...50 Highlights der 37. Auktion am 18. April 2015 - 50 Highlights of Scripophil...
50 Highlights der 37. Auktion am 18. April 2015 - 50 Highlights of Scripophil...
 
Ort business breakfast mailer deloitte final
Ort business breakfast mailer deloitte finalOrt business breakfast mailer deloitte final
Ort business breakfast mailer deloitte final
 
5 cuento fran
5 cuento fran5 cuento fran
5 cuento fran
 
InstantFiler oct 2010
InstantFiler oct 2010InstantFiler oct 2010
InstantFiler oct 2010
 
Cuidadores Clase Lorena Javet
Cuidadores Clase Lorena JavetCuidadores Clase Lorena Javet
Cuidadores Clase Lorena Javet
 
REGIONE VENETO - Turismo flash - Febbraio 2011
REGIONE VENETO - Turismo flash - Febbraio 2011REGIONE VENETO - Turismo flash - Febbraio 2011
REGIONE VENETO - Turismo flash - Febbraio 2011
 
Curriculum Vitae Gianluca Dusio
Curriculum Vitae Gianluca DusioCurriculum Vitae Gianluca Dusio
Curriculum Vitae Gianluca Dusio
 
E2M - Full 3D Black Box Navigation Application for Android
E2M - Full 3D Black Box Navigation Application for AndroidE2M - Full 3D Black Box Navigation Application for Android
E2M - Full 3D Black Box Navigation Application for Android
 
Gbpa porcina
Gbpa porcinaGbpa porcina
Gbpa porcina
 
1 han va cat_trong_dong_tau
1 han va cat_trong_dong_tau1 han va cat_trong_dong_tau
1 han va cat_trong_dong_tau
 
Institucional Agroads.com 2013
Institucional Agroads.com 2013Institucional Agroads.com 2013
Institucional Agroads.com 2013
 
Formato hv foto sena copia2 sammymar
Formato hv foto sena   copia2 sammymarFormato hv foto sena   copia2 sammymar
Formato hv foto sena copia2 sammymar
 
Haris Hamza- Resume
Haris Hamza- ResumeHaris Hamza- Resume
Haris Hamza- Resume
 
La imagen educativa - Cómo se escribe
La imagen educativa - Cómo se escribeLa imagen educativa - Cómo se escribe
La imagen educativa - Cómo se escribe
 
Bases premios i certamen de arte. el valor del vino y el aceite en la cultura...
Bases premios i certamen de arte. el valor del vino y el aceite en la cultura...Bases premios i certamen de arte. el valor del vino y el aceite en la cultura...
Bases premios i certamen de arte. el valor del vino y el aceite en la cultura...
 
gestion infraestructura vial
gestion infraestructura vialgestion infraestructura vial
gestion infraestructura vial
 

Similar to 1945 PHI brochure EN final lowres 130516

UNEP-PSI webinar series "Making inclusive insurance work" - session 3: Health...
UNEP-PSI webinar series "Making inclusive insurance work" - session 3: Health...UNEP-PSI webinar series "Making inclusive insurance work" - session 3: Health...
UNEP-PSI webinar series "Making inclusive insurance work" - session 3: Health...Impact Insurance Facility
 
you have seen that oftentimes the costs and benefits of solutions ar
you have seen that oftentimes the costs and benefits of solutions aryou have seen that oftentimes the costs and benefits of solutions ar
you have seen that oftentimes the costs and benefits of solutions arwalthamcoretta
 
Awareness in india for diabetes mellitus
Awareness in india for diabetes mellitusAwareness in india for diabetes mellitus
Awareness in india for diabetes mellitusgagendra gautam
 
PRIMARY HEALTH CARE -annex (1).pptx
PRIMARY HEALTH CARE -annex (1).pptxPRIMARY HEALTH CARE -annex (1).pptx
PRIMARY HEALTH CARE -annex (1).pptxKeyaArere
 
Health Guardian - Little Green Monsters
Health Guardian - Little Green MonstersHealth Guardian - Little Green Monsters
Health Guardian - Little Green MonstersMannMadeMedia
 
European directory of health apps 2013
European directory of health apps 2013European directory of health apps 2013
European directory of health apps 2013Alfonso Gadea
 
Achieving appropriate design by Michael Free
Achieving appropriate design by Michael FreeAchieving appropriate design by Michael Free
Achieving appropriate design by Michael FreeCara Barnes
 
E health in Nigeria Current Realities and Future Perspectives. A User Centric...
E health in Nigeria Current Realities and Future Perspectives. A User Centric...E health in Nigeria Current Realities and Future Perspectives. A User Centric...
E health in Nigeria Current Realities and Future Perspectives. A User Centric...Ibukun Fowe
 
FNU Community Public Health Nursing as A Frontline Care.docx
FNU Community Public Health Nursing as A Frontline Care.docxFNU Community Public Health Nursing as A Frontline Care.docx
FNU Community Public Health Nursing as A Frontline Care.docxwrite31
 
Community-Based Rehabilitation - Promoting ear and hearing care through CBR b...
Community-Based Rehabilitation - Promoting ear and hearing care through CBR b...Community-Based Rehabilitation - Promoting ear and hearing care through CBR b...
Community-Based Rehabilitation - Promoting ear and hearing care through CBR b...judarobillosnow
 
Stars in Global Health Grant Proposal Version I (2)
Stars in Global Health Grant Proposal Version I (2)Stars in Global Health Grant Proposal Version I (2)
Stars in Global Health Grant Proposal Version I (2)Peter Zhang
 
Health Guardian - Little Green Monsters
Health Guardian - Little Green MonstersHealth Guardian - Little Green Monsters
Health Guardian - Little Green MonstersMannMadeMedia
 
Health guardian little green monsters
Health guardian   little green monstersHealth guardian   little green monsters
Health guardian little green monstersHristo Deliolanov
 
Why advocacymatters
Why advocacymattersWhy advocacymatters
Why advocacymattersclac.cab
 

Similar to 1945 PHI brochure EN final lowres 130516 (20)

UNEP-PSI webinar series "Making inclusive insurance work" - session 3: Health...
UNEP-PSI webinar series "Making inclusive insurance work" - session 3: Health...UNEP-PSI webinar series "Making inclusive insurance work" - session 3: Health...
UNEP-PSI webinar series "Making inclusive insurance work" - session 3: Health...
 
you have seen that oftentimes the costs and benefits of solutions ar
you have seen that oftentimes the costs and benefits of solutions aryou have seen that oftentimes the costs and benefits of solutions ar
you have seen that oftentimes the costs and benefits of solutions ar
 
World report on disability
World report on  disabilityWorld report on  disability
World report on disability
 
Awareness in india for diabetes mellitus
Awareness in india for diabetes mellitusAwareness in india for diabetes mellitus
Awareness in india for diabetes mellitus
 
PRIMARY HEALTH CARE -annex (1).pptx
PRIMARY HEALTH CARE -annex (1).pptxPRIMARY HEALTH CARE -annex (1).pptx
PRIMARY HEALTH CARE -annex (1).pptx
 
Health Guardian - Little Green Monsters
Health Guardian - Little Green MonstersHealth Guardian - Little Green Monsters
Health Guardian - Little Green Monsters
 
APPA555
APPA555APPA555
APPA555
 
European directory of health apps 2013
European directory of health apps 2013European directory of health apps 2013
European directory of health apps 2013
 
Achieving appropriate design by Michael Free
Achieving appropriate design by Michael FreeAchieving appropriate design by Michael Free
Achieving appropriate design by Michael Free
 
Report
ReportReport
Report
 
E health in Nigeria Current Realities and Future Perspectives. A User Centric...
E health in Nigeria Current Realities and Future Perspectives. A User Centric...E health in Nigeria Current Realities and Future Perspectives. A User Centric...
E health in Nigeria Current Realities and Future Perspectives. A User Centric...
 
FNU Community Public Health Nursing as A Frontline Care.docx
FNU Community Public Health Nursing as A Frontline Care.docxFNU Community Public Health Nursing as A Frontline Care.docx
FNU Community Public Health Nursing as A Frontline Care.docx
 
Community-Based Rehabilitation - Promoting ear and hearing care through CBR b...
Community-Based Rehabilitation - Promoting ear and hearing care through CBR b...Community-Based Rehabilitation - Promoting ear and hearing care through CBR b...
Community-Based Rehabilitation - Promoting ear and hearing care through CBR b...
 
Stars in Global Health Grant Proposal Version I (2)
Stars in Global Health Grant Proposal Version I (2)Stars in Global Health Grant Proposal Version I (2)
Stars in Global Health Grant Proposal Version I (2)
 
Quality of life experiences No.2
Quality of life experiences No.2Quality of life experiences No.2
Quality of life experiences No.2
 
Health Guardian - Little Green Monsters
Health Guardian - Little Green MonstersHealth Guardian - Little Green Monsters
Health Guardian - Little Green Monsters
 
Health guardian little green monsters
Health guardian   little green monstersHealth guardian   little green monsters
Health guardian little green monsters
 
Why advocacymatters
Why advocacymattersWhy advocacymatters
Why advocacymatters
 
Capacity Statement WHPCA 2015
Capacity Statement WHPCA 2015Capacity Statement WHPCA 2015
Capacity Statement WHPCA 2015
 
892 2455-1-pb
892 2455-1-pb892 2455-1-pb
892 2455-1-pb
 

1945 PHI brochure EN final lowres 130516

  • 1. Priority ssistive Products List The Initiative Improving access to assistive technology for everyone, everywhere EQUIPPING, ENABLINGAND EMPOWERING Photo:CBM/FotoBackofenMhm
  • 2. Improving access to assistive technology for everyone, everywhere
  • 3. Introduction WHO estimates that over one billion people need one or more assistive products. The majority of these are older people and people with disabilities. As people age, including those with disabilities, their function declines in multiple areas and their need for assistive products increases accordingly. As the global population progressively ages and prevalence of noncommunicable diseases rises, the number of people needing assistive products is projected to increase to beyond two billion by 2050. Assistive products enable people to live healthy, productive, independent and dignified lives; to participate in education, the labour market and civic life. Assistive products can also help to reduce the need for formal health and support services, long-term care and the work of caregivers. Without assistive products, people may suffer exclusion, are at risk of isolation and poverty, and may become a burden to their family and on society. The positive impact of assistive products goes far beyond improving the health and well-being of individual users and their families. There are also socioeconomic benefits to be gained, by virtue of reduced direct health and welfare costs (such as recurrent hospital admissions or state benefits), and by enabling a more productive labour force, indirectly stimulating economic growth. Today, even before the predicted steep increases in need for assistive products are established, only around 10% of those in need have access to them. This is due to high costs, limited availability and inadequate financing in many settings, as well as a widespread lack of awareness and suitably trained personnel. To improve access to high quality, affordable assistive products in all countries, the World Health Organization (WHO) is introducing the Priority Assistive Products List (APL). The APL is the first stage of implementing a global commitment to improve access to assistive products – the Global Cooperation on Assistive Technology (GATE). The APL includes 50 priority assistive products, selected on the basis of widespread need and impact on a person’s life. The list will not be restrictive; the aim is to provide Member States with a model from which to develop a national priority assistive products list according to national need and available resources. Like the WHO Model List of Essential Medicines, the APL can also be used to guide product development, production, service delivery, market shaping, procurement, and reimbursement policies (including insurance coverage). The APL will support Member States to fulfil their commitment to improve access to assistive products – as mandated by the United Nations Convention on the Rights of Persons with Disabilities (CRPD). More than 162 Member States have ratified the CRPD, thus committing to ensure access to assistive technology at an affordable cost, and to foster international cooperation in order to achieve this goal (Articles 4, 20, 26 and 32). Member States have also endorsed the Sustainable Development Goals (SDGs). Universal health coverage is central to SDG goal 3 (Ensure healthy lives and promote well-being for all at all ages). Promoting access to assistive products needs to be an integral part of universal health coverage if the SDGs are to be attained. The APL aspires to follow in the footsteps of the WHO Model List of Essential Medicines, which creates awareness among the public, mobilizes resources and stimulates competition. It has also supported countries to develop national lists to promote access in their own contexts. The APL is similarly intended to be a catalyst in promoting access to assistive technology – everywhere and for everyone. More broadly, the GATE Initiative will support the WHO global strategy on people-centred, integrated health services across the life span, as well as action plans on noncommunicable diseases, ageing and health, disability, and mental health. Assistive technology is the application of organized knowledge and skills related to assistive products, including systems and services. Assistive technology is a subset of health technology. Assistive products: Any external product (including devices, equipment, instruments or software), especially produced or generally available, the primary purpose of which is to maintain or improve an individual’s functioning and independence, and thereby promote their well-being. Assistive products are also used to prevent impairments and secondary health conditions. Priority assistive products: Those products that are highly needed, an absolute necessity to maintain or improve an individual’s functioning and which need to be available at a price the community/state can afford. DEFINITIONS 1
  • 4. ASSISTIVE PRODUCTS AREESSENTIAL TOOLSTO: getting out of bed and out of one’s house compensate for an impairment/ a loss of intrinsic capacity older people reduce the consequences of gradual functional decline people with disability people with noncommunicable diseases people with mental health conditions including dementia and autism people with gradual functional decline help minimize the need for caregivers prevent primary and secondary health conditions lower health and welfare costs accessing education, work and employment escaping from poverty and hunger greater mobility, freedom and independence inclusion and participation leading a dignified life Who needs assistive technology? 2 THEPEOPLE WHOMOST NEEDASSISTIVE TECHNOLOGY INCLUDE: ASSISTIVE PRODUCTS ARE OFTENTHEFIRST STEPTOWARDS:
  • 5. Challenges in access In 2011, the WorldReportonDisability collated evidence for the global unmet need for assistive products of all kinds. We now know that many people have little or no access to basic assistive products, even in some high-income countries. Today, few countries have national assistive technology policies or programmes. As a result, access to assistive products is far from universal: the majority are left behind. In many countries, access to assistive products in the public sector is particularly poor or non-existent, leading to high out-of-pocket payments that are a burden for users and their families. People from the poorer sectors of society frequently rely on donations or charitable services, which often focus on provision of large quantities of sub- standard or used products. These are often not appropriate for the user or the context, and may even cause secondary health complications or premature death. Similar scenarios are common in emergency response programmes, where the need for assistive products is high but often neglected. Affordable and appropriate access requires government commitment to adequate and sustained financing, including efficient procurement of appropriate assistive products and delivery systems. In many high- income countries, people are able to access assistive products via health or welfare systems. Where services exist, they are often stand-alone and fragmented. People must often attend multiple appointments at different locations, which are costly and add to the burden on users and caregivers, as well as on health and welfare budgets. The assistive products industry is currently limited and extremely specialized, primarily serving the requirementsofhigh-incomesettings. There is a general lack of state funding, nationwide service delivery systems, user-centred research and development, procurement systems, quality and safety standards, and context-appropriate product design. Trained personnel are essential for the proper prescription, fitting, user training, follow-up and maintenance of assistive products. Without these key steps, assistive products are often abandoned, of little benefit or harmful, all of which result in extra health care/ welfare costs. By supporting coherent, prioritized national assistive technology policies and programmes, the APL is a potential game-changer in improving access to assistive products globally. 3
  • 6. 1 Alarm signallers with light/sound/vibration 2 Audioplayers with DAISY capability 3 Braille displays (note takers) 4 Braille writing equipment/braillers 5 Canes/sticks 6 Chairs for shower/ bath/toilet 7 Closed captioning displays 8 Club foot braces 9 Communication boards/books/cards 10 Communication software 11 Crutches, axillary/ elbow 12 Deafblind communicators Priority ssistive Products List 4
  • 7. 13 Fall detectors 14 Gesture to voice technology 15 Global positioning system (GPS) locators 16 Hand rails/grab bars 17 Hearing aids (digital) and batteries 18 Hearing loops/FM systems 19 Incontinence products, absorbent 20 Keyboard and mouse emulation software 21 Magnifiers, digital hand-held 22 Magnifiers, optical 23 Orthoses, lower limb 24 Orthoses, spinal The Initiative Equipping, enabling and empowering 5
  • 8. 25 Orthoses, upper limb 26 Personal digital assistant (PDA) 27 Personal emergency alarm systems 28 Pill organizers 29 Pressure relief cushions 30 Pressure relief mattresses 31 Prostheses, lower limb 32 Ramps, portable 33 Recorders 34 Rollators 35 Screen readers 36 Simplified mobile phones Priority ssistive Products List 6
  • 9. The Initiative Improving access to assistive technology for everyone, everywhere 37 Spectacles; low vision, short distance, long distance, filters and protection 38 Standing frames, adjustable 39 Therapeutic footwear; diabetic, neuropathic, orthopaedic 40 Time management products 41 Travel aids, portable 42 Tricycles 43 Video communication devices 44 Walking frames/ walkers 45 Watches, talking/ touching 46 Wheelchairs, manual for active use 47 Wheelchairs, manual assistant-controlled 48 Wheelchairs, manual with postural support 49 Wheelchairs, electrically powered 50 White canes 7
  • 10. 8
  • 11. Development of the APL The APL has taken over a year to develop and has involved extensive consultation with experts, including users and their caregivers. The development of the APL has involved four interlinked steps: 1. SCOPING REVIEW A scoping review was carried out to gather evidence from the literature on the efficacy of various assistive products in maintaining or improving an individual’s functioning, independence, quality of life or well-being. Electronic searches in eight databases for articles published between 2000 and 2014 generated 10,961 hits. Following multistage screening, 205 articles were included for data extraction. 2. DELPHI EXERCISE For the first round of a Delphi exercise, 150 assistive products were identified from the reviewed articles and included in a preliminary list. The products were divided into six broad domains (mobility, vision, hearing, communication, cognition and environment). Disability and ageing data from 50 countries were analysed to estimate the need within each domain, and a fixed number of products was allocated to each domain accordingly. The preliminary list was piloted with 30 assistive technology experts from 22 countries. The pilot resulted in an expanded list of 155 products which was used for the first round of the Delphi exercise. A call to take part in the Delphi exercise was sent to assistive technology stakeholders, including professionals and users’ organizations. 200 stakeholders from 52 countries responded. The Delphi exercise consisted of three rounds: Round 1: Participants received a preliminary list of 155 assistive products. They were asked to review the list and propose any additional products that should be included. As a result, an additional 45 products were added to the list. Round 2: Participants received the extended list of 200 products and were asked to select up to 100 assistive products that should be given priority. Round 3: Participants received a list of the 100 highest ranked products from Round 2. They were asked to select up to 50 assistive products that should be given priority. 3. GLOBAL SURVEY To capture the opinions of a larger global population, especially those of users and caregivers, a global survey in 52 languages was launched and made available online for three months. From the list of 100 products generated in Delphi Round 2, respondents were asked to select up to 50 assistive products that they thought should be given priority. The survey was widely disseminated by Member States, UN agencies, WHO offices, collaborating centres and partners, and the International Disability Alliance. 10,208 people from 161 countries took part in the survey, 44% of whom were older people or people with disabilities. The survey succeeded in reaching people with diverse linguistic and socioeconomic backgrounds. 4. CONSENSUS MEETING A two-day consensus meeting was held at WHO headquarters in Geneva, on 21–22 March 2016 to finalize the APL. Seventy participants attended the meeting with representation from every WHO region. The meeting included people working in service provision and at a policy level, researchers and representatives from organizations for people with disabilities and older people, as well as individual users of assistive products. Following extensive discussion and deliberation, an overwhelming consensus was reached on the final list of 50 priority assistive products. 9
  • 12. In order to have maximum possible impact, the APL needs to be supported with additional policy and legislation, resources, and personnel working within integrated health services. Hence, WHO is in the process of developing three additional tools to assist MemberStatestodevelopnationalassistivetechnology policies and programmes, as an integral component of universal health coverage. These tools include: Policy: Assistive technology policy framework WHO will assist Member States to initiate national policy dialogues to develop national assistive technology programmes. A WHO Model assistive technology policy framework will support this process, with best practice examples. It will include financing mechanisms, such as health and welfare insurance programmes, to help ensure sustainability of service provision and universal access. The policy framework will also include guidance on implementation of the APL, standards, training, and service delivery systems. Personnel: Assistive products training package WHO will support Member States to develop the capacity of their health workforce through an assistive products training package. Existing health and rehabilitation personnel will add to their skillset in order to provide a range of basic assistive products at the primary health care or community level, including the training of formal and informal caregivers. For assistive products that require specialist training (for example, prostheses or spectacles for low vision), WHO will work with Member States to explore possibilities for increasing local or regional capacity for specialist training. The assistive products training package will include four essential steps of service provision: assessment, fitting, training, and follow-up and repair. Next steps 10
  • 13. Provision: Assistive products service delivery model A network of specialist referral centres connected to primary health care infrastructure is needed for universal access to assistive products, and to ensure early intervention. WHO will support Member States to develop a model service delivery system that is best suited for their specific needs. This will enable people to access assistive products for all their functional needs from a single point. WHO will work with Member States to ensure that the service delivery of assistive products becomes an integral part of the health/social welfare system. For further details: The GATE initiative is hosted by the department of essential medicines and products and works across other departments within WHO. For more information: http://www.who.int/phi/implementation/ assistive_technology/en/ 11
  • 14. Acknowledgements Thank you to the following organizations, which have contributed to the development of the APL: Abilia, African Federation of Orthopaedic Technicians, Alzheimer’s Disease International, Association for the Advancement of Assistive Technology in Europe, Canadian Continence Foundation, CBM, CBR Global Network, CBR India Network, CBR Malaysia Network, China Assistive Devices and Technology Centre for Persons with Disabilities, China Disabled Persons’ Federation, Doro, European Assistive Technology Information Network, Fondazione Don Carlo Gnocchi, Foreningen Norges døvblinde, Handicap International, HelpAge International, Hong Kong Society for Rehabilitation, Instituto de Medicina Física e Reabilitação do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, International Committee of the Red Cross, International Disability Alliance, International Society of Prosthetics and Orthotics, International Working Group on the Diabetic Foot, Motivation Australia, Mobility India, Motivation UK, National Rehabilitation Centre for Persons with Disabilities Japan, Office of UN Special Envoy, Perkins School for the Blind, Perspektiva, Ottobock, Rehabilitation Engineering and Assistive Technology Society of Korea, Rehabilitation Engineering and Assistive Technology Society of North America, Rehabilitation Engineering Society of Japan, Sanchar, SINTEF, Stellenbosch University, Trinity College Dublin Centre for Global Health, United States Agency for International Development, UCP Wheels for humanity, Uhambo Foundation, University of Colombo, University of Pittsburgh, World Blind Union, World Confederation of Physical Therapy, World Federation of Occupational Therapists, Zuyd University of Applied Sciences. We also thank the following individuals, who have also contributed to the development of the APL: Martin Aker, Michael Allen, Serap Alsancak, Natasha Altin, Renzo Andrich, Ismet Bajrami, Arjen Bergsma, Girma Bireda Assena, Johan Borg, Penny Bundoc, Tomas Čereška, Gautam Chowdhury, Cristina Maria Correia Cardoso, Jie Dai, Alireza Darvishy, Tulika Das, Luc De Witte, Mareike Decker, Sunil Deepak, Vinicius Delgado Ramos, Biushnu Dhungana, Mukesh Doshi, Pham Dung, Robi Kishore Dutta, Valerio Gower, Edith Hagedoren, Zee-A Han, Kristin Horn, Yunyi Hu, Eldar Husanovic, Erlisi Iljazi, Eduardo Inglez Yamanaka, Cristian Ispas, Vilija Juškienė, Norah Keitany, Nejla Khadri, Mohammed Khadri, Razi Khan, Zia Khan, Phatcharaporn Kongkerd, Anarème Kpandressi, Hung Hei Kwan, Anna Lapinska, Frank Lunde, Maryam Mallick, Katerina Mavrou, Padmani Mendis, Satish Mishra, Inchyuk Moon, Nela Mujacic, Farzaneh Naghshineh, Kozo Nakamura, Yoko Nishimura, Achille Otou-Essono, Timothee Pakouyowou, Jingwen Peng, Tanya Prasolava, Sheila Purves, Malek Qutteina, Ganna Radysh, Uta Roentgen, Joan Ruto, Dovilė Sabaliauskaitė, Kjersti Sagstad, Daniel Scheidegger, Christian Schlierf, Albina Shankar, Dusan Simsik, Anna Söderberg, Terje Sund, Inoue Takenobu, Claude Tardif, Ephrem Taye, Damaijanti Teguh, Outi Töytäri, Patricia Traub, Kai Ming Tsui, Batdulam Tumenbayar, Isabelle Urseau, Miguel Ángel Valero Duboy, Isabel Valle Gallego, Armando Jose Vasquez, Prashannata Wasti, Wang Wei, Petra Winkelmann, Cheryl Ann Xavier, Nan Xia, Noor Yasmin, Diana Zandi, Yan Zhang. 12
  • 15. WHO/EMP/PHI/2016.01 © World Health Organization 2016 All rights reserved. Publications of the World Health Organization are available on the WHO website (http://www. who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications – whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (http://www.who.int/about/licensing/ copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. Financial support: US Agency for International Development Printed in France Designed by Inís Communication – www.iniscommuniation.com Photo credits: Abilia, Cedaf/Guatemala/Patricia Catellanos de Muñoz, WHO/Eduardo Martino, WHO/Pakistan, WHO/Pierre Virot, WHO/SEARO/Vismita Gupta-Smith